Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Ali

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Hardwarex|March 19, 2026
A lab-scale biofiltration system for mitigating diluted methane emissionsTate Geiger, Camila González, Johannes Ali, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2025
Local Single-Dose Radiation Improves Adoptive Cell Therapy With Tumor-Infiltrating LymphocytesNina Obertopp, Rebecca A Bekker, G Daniel Grass, et al.
Frontiers in Immunology|October 30, 2023
Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancerSarah Bazargan, Brittany Bunch, Awino Maureiq E Ojwang', et al.
European Urology|September 17, 2025
Feasibility and Functional Reactivity of Expanded Tumor-infiltrating Lymphocytes from Non-clear-cell Renal Cell CarcinomaMarine Potez, Seyed Behzad Jazayeri, Christopher Guske, et al.
Transplantation and Cellular Therapy|December 20, 2025
Safety and efficacy of tumor-infiltrating lymphocyte (TIL) therapy with reduced-dose lymphodepleting conditioning in high-risk metastatic melanoma patientsLilit Karapetyan, Joel Kuriakose, Elizabeth DiMaggio, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Hardwarex|March 19, 2026
A lab-scale biofiltration system for mitigating diluted methane emissionsTate Geiger, Camila González, Johannes Ali, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2025
Local Single-Dose Radiation Improves Adoptive Cell Therapy With Tumor-Infiltrating LymphocytesNina Obertopp, Rebecca A Bekker, G Daniel Grass, et al.
Frontiers in Immunology|October 30, 2023
Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancerSarah Bazargan, Brittany Bunch, Awino Maureiq E Ojwang', et al.
European Urology|September 17, 2025
Feasibility and Functional Reactivity of Expanded Tumor-infiltrating Lymphocytes from Non-clear-cell Renal Cell CarcinomaMarine Potez, Seyed Behzad Jazayeri, Christopher Guske, et al.
Transplantation and Cellular Therapy|December 20, 2025
Safety and efficacy of tumor-infiltrating lymphocyte (TIL) therapy with reduced-dose lymphodepleting conditioning in high-risk metastatic melanoma patientsLilit Karapetyan, Joel Kuriakose, Elizabeth DiMaggio, et al.
Pageof 1